|
[1]
|
中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版) [J]. 中华内分泌代谢杂志, 2020, 36(9): 727-736. [Google Scholar] [CrossRef]
|
|
[2]
|
郑芬萍, 李红. 原发性醛固酮增多症的规范化诊治[J]. 浙江医学, 2021, 43(21): 2279-2283.
|
|
[3]
|
Lother, A., Moser, M., Bode, C., Feldman, R.D. and Hein, L. (2015) Mineralocorticoids in the Heart and Vasculature: New Insights for Old Hormones. Annual Review of Pharmacology and Toxicology, 55, 289-312. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Brown, J.M., Siddiqui, M., Calhoun, D.A., Carey, R.M., Hopkins, P.N., Williams, G.H., et al. (2020) The Unrecognized Prevalence of Primary Aldosteronism: A Cross-Sectional Study. Annals of Internal Medicine, 173, 10-20. [Google Scholar] [CrossRef]
|
|
[5]
|
Funder, J.W. (2020) Primary Aldosteronism: At the Tipping Point. Annals of Internal Medicine, 173, 65-66. [Google Scholar] [CrossRef]
|
|
[6]
|
李元美, 任艳, 陈涛, 田浩明. 原发性醛固酮增多症诊断与研究进展[J]. 四川大学学报(医学版), 2020, 51(3): 267-277. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
刘圣琢, 董强, 陈涛, 周亮, 刘志洪, 朱育春. 原发性醛固酮增多症亚型诊断金标准——分侧肾上腺静脉采血[J]. 中华内分泌外科杂志, 2019, 13(4): 343-345. [Google Scholar] [CrossRef]
|
|
[8]
|
Vaidya, A., Mu-latero, P., Baudrand, R. and Adler, G.K. (2018) The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. Endocrine Reviews, 39, 1057-1088. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Mihailidou, A.S. (2012) Aldosterone in Heart Disease. Current Hy-pertension Reports, 14, 125-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Monticone, S., D’Ascenzo, F., Moretti, C., Williams, T.A., Veglio, F., Gaita, F., et al. (2018) Cardiovascular Events and Target Organ Damage in Primary Aldosteronism Compared with Essential Hypertension: A Systematic Review and Meta-Analysis. The Lancet Diabetes & Endocrinology, 6, 41-50. [Google Scholar] [CrossRef]
|
|
[11]
|
De Cario, R., Sticchi, E., Lucarini, L., Attanasio, M., Nistri, S., Marcucci, R., et al. (2018) Role of TGFBR1 and TGFBR2 Genetic Variants in Marfan Syndrome. Journal of Vascu-lar Surgery, 68, 225-233.e5. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Humphrey, J.D., Tellides, G. (2019) Central Artery Stiffness and Thoracic Aortopathy. American Journal of Physiology: Heart and Circulatory Physiology, 316, H169-H182. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Chan, Y.C., Ting, C.W., Ho, P., Poon, J.T., Cheung, G.C. and Cheng, S.W. (2008) Ten-Year Epidemiological Review of In-Hospital Patients with Marfan Syndrome. Annals of Vas-cular Surgery, 22, 608-612. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Abu-Halima, M., Kahraman, M., Henn, D., Rädle-Hurst, T., Kel-ler, A., Abdul-Khaliq, H., et al. (2018) Deregulated MicroRNA and mRNA Expression Profiles in the Peripheral Blood of Patients with Marfan Syndrome. Journal of Translational Medicine, 16, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Pinard, A., Jones, G.T. and Milewicz, D.M. (2019) Genetics of Thoracic and Abdominal Aortic Diseases. Circulation Research, 124, 588-606. [Google Scholar] [CrossRef]
|